Alcon Inc
ALC: XSWX (CHE)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
CHF 53.00 | Cbbbx | Pmzwdfnrz |
Alcon's Solid Execution and New Innovation Spark Market Penetration and Long-Term Growth
Business Strategy and Outlook
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: vision care and surgical.